Caelum Biosciences to be acquired by division of AstraZeneca in $150M deal
September 30, 2021 at 14:52 PM EDT
The deal's value could grow by up to another $350 million if a series of product development milestones are met.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
